BMY-28100, A NEW ORAL CEPHALOSPORIN - ANTIMICROBIAL ACTIVITY AGAINST NEARLY 7,000 RECENT CLINICAL ISOLATES, COMPARATIVE POTENCY WITH OTHER ORAL-AGENTS, AND ACTIVITY AGAINST BETA-LACTAMASE PRODUCING ISOLATES

被引:24
作者
JONES, RN
BARRY, AL
机构
关键词
D O I
10.1016/0732-8893(88)90056-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:11 / 26
页数:16
相关论文
共 21 条